Drugs / naidaplatin
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05628610 | Sep 2024 → Sep 2026 expected | esophageal cancer | Fujian Cancer Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | naidaplatin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05628610 ↗ |